Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).

Abstract

Low serum albumin (SA) on admission in patients with acute myocardial infarction (AMI) has been reported to be associated with adverse cardiovascular events. The relation between low SA and post-AMI bleeding events is presently unknown. We analyzed 1,724 patients with AMI enrolled in the HAGAKURE-ACS registry who underwent primary percutaneous coronary intervention from January 2014 to December 2018. To assess the influence of low SA at admission, patients were divided into 3 groups according to the albumin tertiles: the low SA group (<3.8 g/100 ml), the middle SA (MSA) group (3.8 to 4.1 g/100 ml), and the normal SA (NSA) group (≥4.2 g/100 ml). The primary end point was the incidence of Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries moderate/severe bleeding. The cumulative 3-year incidence of the primary end point was significantly higher in the low SA group than in the MSA and NSA groups (30.8% and 11.9% vs 7.7%; p <0.001). In the landmark analysis at 30 days, the cumulative incidences of the primary end point were also significantly higher in the low SA group than in the MSA and NSA groups, both within and beyond 30 days (20.1% and 6.1% vs 3.5%; p <0.001, and 12.4% and 6.2% vs 4.5%; p <0.001, respectively). After adjusting for confounders, the low SA group showed excess risk of bleeding events relative to NSA (hazard ratio 1.56; 95% confidence interval 1.06 to 2.30; p = 0.026), whereas risk of bleeding was neutral in MSA relative to NSA (hazard ratio 0.94; 95% confidence interval 0.63 to 1.34; p = 0.752). In conclusion, low SA at admission was independently associated with higher risk for bleeding events in patients with AMI undergoing percutaneous coronary intervention.

• Authors: Goro Yoshioka, Masahiro Natsuaki, Yuhei Goriki, Kodai Shinzato, Kensaku Nishihira, Nehiro Kuriyama, Mitsuhiro Shimomura, Yohei Inoue, Toshiyuki Nishikido, Hiroshi Hongo, Tetsuya Kaneko, Kohei Kamishita, Kensuke Yokoi, Ayumu Yajima, Yoshiko Sakamoto, Motoko Tago, Atsushi Kawaguchi, Takanori Yamaguchi, Machiko Asaka, Norihiko Kotooka, Shinjo Sonoda, Yutaka Hikichi, Yoshisato Shibata, Koichi Node
• Journal: The American journal of cardiology (Am J Cardiol) Vol. 165 Pg. 19-26 (02 15 2022) ISSN: 1879-1913 [Electronic] United States
• PMID: 34893303 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Elsevier Inc. All rights reserved.

Chemical References

• Serum Albumin

Topics

• Aged
• Aged, 80 and over
• Anemia (epidemiology)
• Atrial Fibrillation (epidemiology)
• Diabetes Mellitus (epidemiology)
• Female
• Humans
• Hypoalbuminemia (epidemiology, metabolism)
• Japan (epidemiology)
• Male
• Middle Aged
• Myocardial Infarction (epidemiology, surgery)
• Neoplasms (epidemiology)
• Non-ST Elevated Myocardial Infarction (epidemiology, surgery)
• Percutaneous Coronary Intervention
• Postoperative Hemorrhage (epidemiology)
• Registries
• Renal Insufficiency, Chronic (epidemiology)
• ST Elevation Myocardial Infarction (epidemiology, surgery)
• Serum Albumin (metabolism)
• Smoking (epidemiology)